| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | Venker Eric President & Immunovant CEO | Sale | -200,000 | -11.03%1,613,063 | $30.27 | $6,054,000 | View SEC filing | |
| 2026-04-22 | Venker Eric President & Immunovant CEO | Sale | -200,000 | -10.83%1,647,546 | $29.59 | $5,918,000 | View SEC filing | |
| 2026-04-20 | Gline Matthew CEO | Sale | -289,774 | -1.70%16,736,116 | $29.16 | $8,449,810 | View SEC filing | |
| 2026-04-10 | Humes Jennifer Chief Accounting Officer | Sale | -13,538 | -13.85%84,191 | $28.37 | $384,073 | View SEC filing | |
| 2026-03-30 | Fitzgerald Meghan Director | Sale | -70,000 | -61.97%42,963 | $27.45 | $1,921,500 | View SEC filing | |
| 2026-03-19 | Venker Eric President & Immunovant CEO | Sale | -200,000 | -10.83%1,647,546 | $28.24 | $5,648,000 | View SEC filing | |
| 2026-03-18 | Epperly Melissa B, Director | Sale | -41,861 | -72.59%15,804 | $28.68 | $1,200,573 | View SEC filing | |
| 2026-02-23 | Torti Frank President and Vant Chair | Sale | -3,000,000 | -9.25%13,736,547 | $27.35 | $82,039,460 | View SEC filing | |
| 2026-02-18 | Venker Eric President & Immunovant CEO | Sale | -200,000 | -10.78%1,654,597 | $26.49 | $5,298,000 | View SEC filing | |
| 2026-02-13 | MANCHESTER KEITH S Director | Sale | -1,225,784 | -7.50%15,127,329 | $26.64 | $32,658,518 | View SEC filing | |
| 2026-02-13 | Gold Daniel Allen Director | Sale | -1,225,784 | -7.50%15,127,329 | $26.64 | $32,658,518 | View SEC filing | |
| 2026-02-13 | QVT Financial LP Other | Sale | -1,225,784 | -7.50%15,127,329 | $26.64 | $32,658,518 | View SEC filing | |
| 2026-02-11 | Sukhatme Mayukh President & CIO | Sale | -339,441 | -1.74%19,148,664 | $26.47 | $8,985,003 | View SEC filing | |
| 2026-01-14 | Venker Eric President & Immunovant CEO | Sale | -200,000 | -10.78%1,654,597 | $21.92 | $4,384,000 | View SEC filing | |
| 2025-12-31 | Sukhatme Mayukh President & CIO | Sale | -1,330,868 | +3.48%20,267,429 | $21.72 | $28,902,500 | View SEC filing | |
| 2025-12-29 | Pulik Richard CFO | Sale | -406,731 | -62.95%239,413 | $22.43 | $9,122,307 | View SEC filing | |
| 2025-12-29 | Venker Eric President & Immunovant CEO | Sale | -275,000 | -8.67%1,654,597 | $22.47 | $6,179,750 | View SEC filing | |
| 2025-12-19 | Sukhatme Mayukh President & CIO | Sale | -26,831 | -0.14%18,869,229 | $23.09 | $619,528 | View SEC filing | |
| 2025-12-18 | Gold Daniel Allen Director | Sale | -1,694,614 | -9.39%16,353,113 | $23.05 | $39,065,213 | View SEC filing | |
| 2025-12-18 | MANCHESTER KEITH S Director | Sale | -1,694,614 | -9.39%16,353,113 | $23.05 | $39,065,213 | View SEC filing | |
| 2025-12-18 | QVT Financial LP Other | Sale | -1,694,614 | -9.39%16,353,113 | $23.05 | $39,065,213 | View SEC filing | |
| 2025-12-17 | Gline Matthew CEO | Sale | -1,740,000 | +6.25%18,616,406 | $21.68 | $37,723,200 | View SEC filing | |
| 2025-12-15 | Ramaswamy Vivek 10% Owner | Sale | -3,103,745 | -3.92%34,132,463 | $21.89 | $67,942,352 | View SEC filing | |
| 2025-12-11 | Venker Eric President & Immunovant CEO | Sale | -200,000 | -11.78%1,497,908 | $20.85 | $4,170,000 | View SEC filing | |
| 2025-11-21 | MANCHESTER KEITH S Director | Sale | -1,300,000 | -6.72%18,047,727 | $20.23 | $26,304,500 | View SEC filing |
1-25 of 134
